Work

P3.02c-056 Interim Results From the Phase I Study of Nivolumab + nab-Paclitaxel + Carboplatin in Non-Small Cell Lung Cancer (NSCLC)

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.1851

Authors: Jonathan W. Goldman, Ben George, Martin Gutierrez, Amy Ko, Peter O'Dwyer, Gregory Otterson, Hatem Soliman, Nataliya Trunova, David Waterhouse, Karen Kelly

Institutions: University of California, Los Angeles, Medical College of Wisconsin, Hackensack University Medical Center, Celgene (United States), Abramson Cancer Center, University of Pennsylvania, The Ohio State University, University of South Florida, Moffitt Cancer Center, Oncology Hematology Care, UC Davis Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2569330503

FWCI:

Cites:

Cited by:

Related to: 10